An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)
This study has been completed.
Sponsor:
Alza Corporation, DE, USA
Information provided by:
Alza Corporation, DE, USA
ClinicalTrials.gov Identifier:
NCT00399048
First received: November 10, 2006
Last updated: April 26, 2010
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2001 |
| Estimated Primary Completion Date: | No date given |